Giannina Rita Iannotti, PhD-PD
Switzerland
Centre de médecine virtuelle
Olivier Kannape
Switzerland
The labeling of a database guarantees its compliance and increases its national and international visibility.
The labeling of a biobank facilitates exchanges with other research groups while respecting regulations regarding transfer of scientific material.
For funding requests, a labeled biobank is a proof of quality.
For all these reasons, the NeuroCentre helps to prepare documents needed for the labeling of your biobank by the Swiss Biobanking platform.
Intracranial aneurysm, which is a local growth of a cerebral artery, is present in 3 to 5% of the population. Once formed, an intracranial aneurysm may remain stable, grow, or rupture. Its rupture leads to subarachnoid hemorrhage which has serious consequences in terms of death, disability and socio-economic burden.
The objective of our work is to better understand the pathophysiology of intracranial aneurysms in order to determine which aneurysms are at risk of rupture and which are not.
The labeling of our biobank AneuX makes it possible to collaborate at the national and international level in order to increase the number of data and samples.
The AneuX biobank is made up of domes of human cerebral aneurysms. The dome of the aneurysm is resected after clipping the aneurysmal neck during microsurgery performed for the treatment of the aneurysm.
All samples are collected at the HUG Neurosurgery Division. After formalin fixation, the aneurysm domes are embedded in paraffin.
For more information on this biobank and on studies on intracranial aneurysms, and to join our consortium: Aneurysm Databank.
